Annual D&A
$104.39 M
+$2.42 M+2.37%
31 December 2023
Summary:
BioMarin Pharmaceutical annual depreciation & amortization is currently $104.39 million, with the most recent change of +$2.42 million (+2.37%) on 31 December 2023. During the last 3 years, it has fallen by -$3.65 million (-3.38%). BMRN annual D&A is now -3.38% below its all-time high of $108.04 million, reached on 31 December 2021.BMRN Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly D&A
$19.01 M
-$7.46 M-28.18%
30 September 2024
Summary:
BioMarin Pharmaceutical quarterly depreciation & amortization is currently $19.01 million, with the most recent change of -$7.46 million (-28.18%) on 30 September 2024. Over the past year, it has dropped by -$7.86 million (-29.24%). BMRN quarterly D&A is now -38.17% below its all-time high of $30.74 million, reached on 30 September 2019.BMRN Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM D&A
$99.68 M
-$6.68 M-6.28%
30 September 2024
Summary:
BioMarin Pharmaceutical TTM depreciation & amortization is currently $99.68 million, with the most recent change of -$6.68 million (-6.28%) on 30 September 2024. Over the past year, it has dropped by -$4.71 million (-4.51%). BMRN TTM D&A is now -8.89% below its all-time high of $109.41 million, reached on 30 September 2021.BMRN TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BMRN Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -29.2% | -4.5% |
| 3 y3 years | -3.4% | -26.9% | -7.7% |
| 5 y5 years | -0.9% | -26.3% | -5.3% |
BMRN Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -3.4% | +2.4% | -30.5% | at low | -7.7% | at low |
| 5 y | 5 years | -3.4% | +2.4% | -32.1% | at low | -8.9% | at low |
| alltime | all time | -3.4% | >+9999.0% | -38.2% | +1355.3% | -8.9% | +9978.9% |
BioMarin Pharmaceutical Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $19.01 M(-28.2%) | $99.68 M(-6.3%) |
| June 2024 | - | $26.46 M(-3.2%) | $106.36 M(+1.0%) |
| Mar 2024 | - | $27.35 M(+1.8%) | $105.31 M(+0.9%) |
| Dec 2023 | $104.39 M(+2.4%) | $26.86 M(+4.6%) | $104.39 M(+2.3%) |
| Sept 2023 | - | $25.68 M(+1.0%) | $102.08 M(+0.9%) |
| June 2023 | - | $25.42 M(-3.8%) | $101.19 M(+0.1%) |
| Mar 2023 | - | $26.42 M(+7.6%) | $101.05 M(-0.9%) |
| Dec 2022 | $101.97 M(-5.6%) | $24.55 M(-1.0%) | $101.97 M(-1.4%) |
| Sept 2022 | - | $24.80 M(-1.9%) | $103.40 M(-1.9%) |
| June 2022 | - | $25.27 M(-7.6%) | $105.44 M(-1.8%) |
| Mar 2022 | - | $27.34 M(+5.2%) | $107.40 M(-0.6%) |
| Dec 2021 | $108.04 M(+2.7%) | $25.99 M(-3.2%) | $108.04 M(-1.3%) |
| Sept 2021 | - | $26.84 M(-1.4%) | $109.41 M(+0.2%) |
| June 2021 | - | $27.23 M(-2.7%) | $109.21 M(+1.9%) |
| Mar 2021 | - | $27.98 M(+2.3%) | $107.19 M(+1.9%) |
| Dec 2020 | $105.17 M(-0.1%) | $27.36 M(+2.7%) | $105.17 M(+1.5%) |
| Sept 2020 | - | $26.63 M(+5.6%) | $103.60 M(-3.8%) |
| June 2020 | - | $25.22 M(-2.9%) | $107.71 M(-1.0%) |
| Mar 2020 | - | $25.96 M(+0.7%) | $108.84 M(+3.4%) |
| Dec 2019 | $105.30 M(+10.1%) | $25.79 M(-16.1%) | $105.30 M(+1.0%) |
| Sept 2019 | - | $30.74 M(+16.7%) | $104.23 M(+4.4%) |
| June 2019 | - | $26.34 M(+17.5%) | $99.83 M(+5.7%) |
| Mar 2019 | - | $22.43 M(-9.3%) | $94.47 M(-1.3%) |
| Dec 2018 | $95.67 M(+8.9%) | $24.72 M(-6.2%) | $95.67 M(-4.0%) |
| Sept 2018 | - | $26.34 M(+25.6%) | $99.62 M(+6.0%) |
| June 2018 | - | $20.98 M(-11.2%) | $93.97 M(+2.1%) |
| Mar 2018 | - | $23.63 M(-17.6%) | $92.08 M(+4.8%) |
| Dec 2017 | $87.86 M(-9.3%) | $28.66 M(+38.5%) | $87.86 M(+10.8%) |
| Sept 2017 | - | $20.70 M(+8.5%) | $79.30 M(-9.9%) |
| June 2017 | - | $19.09 M(-1.7%) | $88.03 M(-9.8%) |
| Mar 2017 | - | $19.41 M(-3.5%) | $97.60 M(+0.7%) |
| Dec 2016 | $96.91 M(+105.4%) | $20.11 M(-31.7%) | $96.91 M(+8.1%) |
| Sept 2016 | - | $29.42 M(+2.7%) | $89.69 M(+24.0%) |
| June 2016 | - | $28.66 M(+53.0%) | $72.31 M(+31.2%) |
| Mar 2016 | - | $18.73 M(+45.3%) | $55.10 M(+16.8%) |
| Dec 2015 | $47.19 M(+2.9%) | $12.89 M(+7.0%) | $47.19 M(+17.2%) |
| Sept 2015 | - | $12.04 M(+5.2%) | $40.27 M(-5.2%) |
| June 2015 | - | $11.45 M(+5.8%) | $42.45 M(-5.0%) |
| Mar 2015 | - | $10.82 M(+81.3%) | $44.68 M(-2.6%) |
| Dec 2014 | $45.87 M(+27.4%) | $5.97 M(-58.1%) | $45.87 M(+19.5%) |
| Sept 2014 | - | $14.22 M(+4.0%) | $38.39 M(+2.4%) |
| June 2014 | - | $13.68 M(+13.9%) | $37.48 M(+2.2%) |
| Mar 2014 | - | $12.00 M(-892.9%) | $36.67 M(+1.8%) |
| Dec 2013 | $36.01 M(-18.8%) | -$1.51 M(-111.4%) | $36.01 M(-25.6%) |
| Sept 2013 | - | $13.31 M(+3.5%) | $48.42 M(+3.5%) |
| June 2013 | - | $12.87 M(+13.4%) | $46.78 M(+3.8%) |
| Mar 2013 | - | $11.35 M(+4.1%) | $45.09 M(+1.7%) |
| Dec 2012 | $44.34 M(+26.5%) | $10.90 M(-6.6%) | $44.34 M(+5.5%) |
| Sept 2012 | - | $11.67 M(+4.4%) | $42.02 M(+5.8%) |
| June 2012 | - | $11.17 M(+5.4%) | $39.70 M(+7.1%) |
| Mar 2012 | - | $10.60 M(+23.5%) | $37.06 M(+5.7%) |
| Dec 2011 | $35.05 M | $8.58 M(-8.2%) | $35.05 M(+1.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2011 | - | $9.35 M(+9.6%) | $34.40 M(+4.7%) |
| June 2011 | - | $8.53 M(-0.6%) | $32.87 M(+6.3%) |
| Mar 2011 | - | $8.59 M(+8.2%) | $30.91 M(+11.4%) |
| Dec 2010 | $27.74 M(+32.2%) | $7.93 M(+1.4%) | $27.74 M(+12.4%) |
| Sept 2010 | - | $7.82 M(+18.9%) | $24.67 M(+13.7%) |
| June 2010 | - | $6.58 M(+21.6%) | $21.69 M(+1.9%) |
| Mar 2010 | - | $5.41 M(+11.3%) | $21.28 M(+1.5%) |
| Dec 2009 | $20.98 M(+19.1%) | $4.86 M(+0.4%) | $20.98 M(+0.6%) |
| Sept 2009 | - | $4.84 M(-21.5%) | $20.86 M(-16.1%) |
| June 2009 | - | $6.17 M(+20.9%) | $24.85 M(+14.6%) |
| Mar 2009 | - | $5.10 M(+7.6%) | $21.69 M(+23.1%) |
| Dec 2008 | $17.62 M(+1516.1%) | $4.74 M(-46.3%) | $17.62 M(+35.2%) |
| Sept 2008 | - | $8.84 M(+193.8%) | $13.03 M(+214.1%) |
| June 2008 | - | $3.01 M(+191.7%) | $4.15 M(+224.6%) |
| Mar 2008 | - | $1.03 M(+556.7%) | $1.28 M(+17.2%) |
| Dec 2007 | $1.09 M(-88.9%) | $157.00 K(-441.3%) | $1.09 M(-17.9%) |
| Sept 2007 | - | -$46.00 K(-133.8%) | $1.33 M(-70.2%) |
| June 2007 | - | $136.00 K(-83.9%) | $4.46 M(-44.9%) |
| Mar 2007 | - | $843.00 K(+114.0%) | $8.10 M(-17.3%) |
| Dec 2006 | $9.79 M(+0.4%) | $394.00 K(-87.2%) | $9.79 M(-17.3%) |
| Sept 2006 | - | $3.09 M(-18.3%) | $11.85 M(+5.9%) |
| June 2006 | - | $3.78 M(+49.0%) | $11.19 M(+14.0%) |
| Mar 2006 | - | $2.54 M(+3.6%) | $9.82 M(+0.7%) |
| Dec 2005 | $9.75 M(-26.6%) | $2.45 M(+0.8%) | $9.75 M(-25.4%) |
| Sept 2005 | - | $2.43 M(+1.0%) | $13.06 M(+2.1%) |
| June 2005 | - | $2.40 M(-2.5%) | $12.79 M(-5.7%) |
| Mar 2005 | - | $2.47 M(-57.2%) | $13.55 M(+2.1%) |
| Dec 2004 | $13.28 M(+40.6%) | $5.76 M(+167.1%) | $13.28 M(+34.1%) |
| Sept 2004 | - | $2.16 M(-32.1%) | $9.90 M(-7.3%) |
| June 2004 | - | $3.17 M(+44.8%) | $10.68 M(+11.9%) |
| Mar 2004 | - | $2.19 M(-8.1%) | $9.55 M(+1.1%) |
| Dec 2003 | $9.44 M(+11.0%) | $2.38 M(-18.7%) | $9.44 M(+5.6%) |
| Sept 2003 | - | $2.93 M(+43.7%) | $8.94 M(+6.6%) |
| June 2003 | - | $2.04 M(-2.2%) | $8.39 M(-1.6%) |
| Mar 2003 | - | $2.08 M(+10.7%) | $8.53 M(+0.3%) |
| Dec 2002 | $8.50 M(+21.4%) | $1.88 M(-20.9%) | $8.50 M(+14.0%) |
| Sept 2002 | - | $2.38 M(+9.3%) | $7.46 M(+2.4%) |
| June 2002 | - | $2.18 M(+5.7%) | $7.28 M(+1.6%) |
| Mar 2002 | - | $2.06 M(+145.6%) | $7.17 M(+2.3%) |
| Dec 2001 | $7.00 M(+22.2%) | $839.00 K(-61.9%) | $7.00 M(+6.8%) |
| Sept 2001 | - | $2.20 M(+6.8%) | $6.56 M(+4.7%) |
| June 2001 | - | $2.06 M(+8.5%) | $6.26 M(+6.2%) |
| Mar 2001 | - | $1.90 M(+381.0%) | $5.90 M(+2.9%) |
| Dec 2000 | $5.73 M(+5.9%) | $395.00 K(-79.3%) | $5.73 M(-12.5%) |
| Sept 2000 | - | $1.91 M(+12.4%) | $6.55 M(-1.4%) |
| June 2000 | - | $1.70 M(-2.1%) | $6.65 M(+7.9%) |
| Mar 2000 | - | $1.73 M(+42.7%) | $6.16 M(+13.8%) |
| Dec 1999 | $5.42 M(+576.9%) | $1.22 M(-39.3%) | $5.42 M(+28.9%) |
| Sept 1999 | - | $2.00 M(+65.2%) | $4.20 M(+90.9%) |
| June 1999 | - | $1.21 M(+22.4%) | $2.20 M(+122.4%) |
| Mar 1999 | - | $989.00 K | $989.00 K |
| Dec 1998 | $800.00 K | - | - |
FAQ
- What is BioMarin Pharmaceutical annual depreciation & amortization?
- What is the all time high annual D&A for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly depreciation & amortization?
- What is the all time high quarterly D&A for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly D&A year-on-year change?
- What is BioMarin Pharmaceutical TTM depreciation & amortization?
- What is the all time high TTM D&A for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical TTM D&A year-on-year change?
What is BioMarin Pharmaceutical annual depreciation & amortization?
The current annual D&A of BMRN is $104.39 M
What is the all time high annual D&A for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual depreciation & amortization is $108.04 M
What is BioMarin Pharmaceutical quarterly depreciation & amortization?
The current quarterly D&A of BMRN is $19.01 M
What is the all time high quarterly D&A for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly depreciation & amortization is $30.74 M
What is BioMarin Pharmaceutical quarterly D&A year-on-year change?
Over the past year, BMRN quarterly depreciation & amortization has changed by -$7.86 M (-29.24%)
What is BioMarin Pharmaceutical TTM depreciation & amortization?
The current TTM D&A of BMRN is $99.68 M
What is the all time high TTM D&A for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high TTM depreciation & amortization is $109.41 M
What is BioMarin Pharmaceutical TTM D&A year-on-year change?
Over the past year, BMRN TTM depreciation & amortization has changed by -$4.71 M (-4.51%)